We are live on
!
Find out more
FA
Fagan Associates Portfolio holdings
AUM
$813M
1-Year Est. Return
37.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.34%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+585.67%
AUM
$246M
AUM Growth
+$12.4M
(+5.3%)
Cap. Flow
+$4M
Cap. Flow
% of AUM
1.62%
Top 10 Holdings %
Top 10 Hldgs %
38.42%
Holding
118
New
7
Increased
68
Reduced
27
Closed
6
Avg Time Held
11.5
quarters
Top 10 Avg Time Held
10.6
quarters
Top 20 Avg Time Held
11.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.81M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$750K |
| 3 |
Walt Disney
DIS
|
+$475K |
| 4 |
Boston Scientific
BSX
|
+$362K |
| 5 |
Equinix
EQIX
|
+$353K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.26M |
| 2 |
Take-Two Interactive
TTWO
|
+$1.95M |
| 3 |
The Mosaic Company
MOS
|
+$802K |
| 4 |
NEWR
New Relic, Inc.
NEWR
|
+$528K |
| 5 |
Fluor
FLR
|
+$210K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.89% |
| 2 | Technology | 18.3% |
| 3 | Financials | 16.78% |
| 4 | Communication Services | 11.51% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
State Street Energy Select Sector SPDR ETF
XLE
$41.9B
| $274K | 0.11% |
8,592
+494
| +6% | +$15.8K |
2019 Q1
1 quarter
|
|
102
Comcast
CMCSA
$73.3B
| $263K | 0.11% |
6,210
+524
| +9% | +$22.1K |
2019 Q1
1 quarter
|
|
103
Pfizer
PFE
$161B
| $262K | 0.11% |
6,383
+933
| +17% | +$37K |
2018 Q3
3 quarters
|
|
|
CONE
104
DELISTED
CyrusOne Inc Common Stock
CONE
| $260K | 0.11% |
+4,505
| New | +$264K |
2019 Q2
0 quarters
|
|
105
Omega Healthcare
OHI
$13.5B
| $244K | 0.1% |
+6,640
| New | +$242K |
2019 Q2
0 quarters
|
|
106
Edwards Lifesciences
EW
$49.1B
| $243K | 0.1% |
3,945
| – | – |
2018 Q2
4 quarters
|
|
107
Schwab US Large- Cap ETF
SCHX
$75.3B
| $224K | 0.09% |
19,128
-300
| -2% | -$3.45K |
2019 Q1
1 quarter
|
|
108
PepsiCo
PEP
$172B
| $221K | 0.09% |
1,684
+1
| +0.1% | +$128 |
2019 Q1
1 quarter
|
|
109
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.8B
| $211K | 0.09% |
8,075
| – | – |
2014 Q2
20 quarters
|
|
110
iShares Core S&P Total US Stock Market ETF
ITOT
$97.9B
| $210K | 0.09% |
+3,155
| New | +$207K |
2019 Q2
0 quarters
|
|
111
American Express
AXP
$208B
| $205K | 0.08% |
+1,660
| New | +$195K |
2019 Q2
0 quarters
|
|
112
Consolidated Edison
ED
$39.2B
| $201K | 0.08% |
+2,288
| New | +$197K |
2019 Q2
0 quarters
|
|
113
Bristol-Myers Squibb
BMY
$121B
| – | – |
-4,310
| Closed | -$206K | – |
|
|
114
Fluor
FLR
$6.78B
| – | – |
-5,705
| Closed | -$210K | – |
|
|
115
The Mosaic Company
MOS
$5.96B
| – | – |
-29,370
| Closed | -$802K | – |
|
|
116
Regeneron Pharmaceuticals
REGN
$76.9B
| – | – |
-550
| Closed | -$2.26M | – |
|
|
117
Take-Two Interactive
TTWO
$39.9B
| – | – |
-20,685
| Closed | -$1.95M | – |
|
|
NEWR
118
DELISTED
New Relic, Inc.
NEWR
| – | – |
-5,350
| Closed | -$528K | – |
|
Similar funds
CFO
REA
TLP
DMC
BPIM
GCM
KCPG
WAM
Fagan Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Fagan Associates held 118 positions worth $246M, up 5.3% from $234M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Fagan Associates's Q2 2019 filing shows 7 new, 68 increased, 27 reduced and 6 closed positions. Its largest new stake was Advanced Micro Devices: 63,470 shares worth $1.93M. The largest sale was Regeneron Pharmaceuticals, an estimated $2.26M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
- Fagan Associates's largest Q2 2019 buy was Advanced Micro Devices: 63,470 shares worth $1.93M.
- Fagan Associates added most to Walt Disney in Q2 2019, an estimated $475K increase.
- Fagan Associates's biggest Q2 2019 reduction was Intel, cutting an estimated $64.4K.
- Fagan Associates fully exited Regeneron Pharmaceuticals in Q2 2019, selling an estimated $2.26M.
- Fagan Associates's ten largest holdings make up 38% of its $246M portfolio in Q2 2019.
- Fagan Associates opened 7 new positions and closed 6 in Q2 2019.
- Fagan Associates's portfolio value rose 5.3% quarter-over-quarter to $246M.
Based on Fagan Associates's 13F filing for Q2 2019, filed 12 Jul 2019.